# Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery

> **NCT01939028** · NA · TERMINATED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 58 (actual)

## Conditions studied

- Stage I Endometrial Carcinoma
- Stage II Endometrial Carcinoma
- Stage III Endometrial Carcinoma
- Stage IV Endometrial Carcinoma

## Interventions

- **PROCEDURE:** lymph node mapping
- **PROCEDURE:** sentinel lymph node biopsy
- **DRUG:** isosulfan blue
- **DRUG:** indocyanine green solution
- **PROCEDURE:** therapeutic conventional surgery
- **PROCEDURE:** lymphadenectomy

## Key facts

- **NCT ID:** NCT01939028
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 58 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2020-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01939028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01939028, "Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01939028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*